Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis
Biomolecules · 2026
DOI: 10.3390/biom16101524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Giulia Guadalupi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences, University of Cagliari, 09121 Cagliari, Italy. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Proteomics, Saliva, Proteome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sardegna Ricerche (Italy).
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic immune-mediated disease for which non-invasive biomarkers, able to detect disease- and treatment-associated molecular changes, are needed. We characterized the whole-saliva proteome of patients with relapsing-remitting (RR) MS at baseline before treatment initiation (MS-T0; n = 66) and after six months of disease-modifying therapy (MS-T1; n = 40), in comparison with healthy controls (HC; n = 31). Nano-liquid chromatography-high-resolution tandem mass spectrometry identified 1305 proteins, of which 209 differed among the main comparisons. Pairwise and paired analyses distinguished persistent RRMS-associated alterations, baseline-attenuation patterns with changes shifting towards HC levels, treatment-associated differences emerging at MS-T1, and longitudinal-only alterations. The identified patterns are descriptive and cannot be interpreted as evidence of pharmacological treatment effects or clinical response. The existence of specific RRMS alterations was supported by exploratory Random Forest, which classified HC, MS-T0 and MS-T1 samples using a panel of 50 proteins, most of which (96%) also showed significant changes in univariate tests. Reactome enrichment evidenced that proteins pertaining to the identified patterns are mainly involved in innate immunity, neutrophil degranulation, cell-death pathways, cytokine signalling, and protein folding. These findings indicate that six months of therapy was associated with substantial salivary proteome changes and support saliva as a candidate biofluid for longitudinal molecular monitoring and non-invasive detection of treatment-associated salivary proteome variations in RRMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life and Environmental Sciences, University of Cagliari, 09121 Cagliari, Italy.
- Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, University of Cagliari, 09126 Cagliari, Italy.
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Department of Biomedical Sciences, University of Cagliari, 09121 Cagliari, Italy.
ORCID-Profile: Giulia Guadalupi, Cristina Contini, Greca Lai, Massimo Castagnola, Irene Messana, Giacomo Diaz, Tiziana Cabras, Alessandra Olianas, Eleonora Cocco, Barbara Manconi, Lorena Lorefice
Förderung
- Sardegna Ricerche (Italy)
Zitieren
APA
Guadalupi, G., Contini, C., Piras, C., Pisano, G., Frau, J., Fenu, G., Coghe, G., Lai, G., Castagnola, M., Messana, I., Diaz, G., Cabras, T., Olianas, A., Cocco, E., Manconi, B., & Lorefice, L. (2026). Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis. Biomolecules. https://doi.org/10.3390/biom16101524
Vancouver
Guadalupi G, Contini C, Piras C, Pisano G, Frau J, Fenu G, et al. Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis. Biomolecules. 2026. doi:10.3390/biom16101524
BibTeX
@article{Guadalupi2026,
author = {Guadalupi, Giulia and Contini, Cristina and Piras, Chiara and Pisano, Giada and Frau, Jessica and Fenu, Giuseppe and Coghe, Giancarlo and Lai, Greca and Castagnola, Massimo and Messana, Irene and Diaz, Giacomo and Cabras, Tiziana and Olianas, Alessandra and Cocco, Eleonora and Manconi, Barbara and Lorefice, Lorena},
title = {Salivary Proteomics Reveals Disease- and Therapy-Associated Molecular Patterns in Relapsing-Remitting Multiple Sclerosis},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16101524}
}
EUVIMED